BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Su CH, Tsay SH, Wu CC, Shyr YM, King KL, Lee CH, Lui WY, Liu TJ, P'eng FK. Factors influencing postoperative morbidity, mortality, and survival after resection for hilar cholangiocarcinoma. Ann Surg. 1996;223:384-394. [PMID: 8633917 DOI: 10.1097/00000658-199604000-00007] [Cited by in Crossref: 187] [Cited by in F6Publishing: 188] [Article Influence: 7.2] [Reference Citation Analysis]
Number Citing Articles
1 Maeda A, Goto S, Iwasaki R, Yamada K, Murakami M, Sakai H, Mori T. Outcome of Localized Bile Duct Carcinoma in Six Dogs Treated with Liver Lobectomy. J Am Anim Hosp Assoc 2022;58:189-93. [PMID: 35793487 DOI: 10.5326/JAAHA-MS-7199] [Reference Citation Analysis]
2 Ersan V, Usta S, Aydin C, Carr BI, Karatoprak S, Yilmaz S. Critical overview of resection for Bismuth-Corlette type IV perihilar cholangiocarcinoma. Acta Chir Belg 2022;:1-8. [PMID: 35549649 DOI: 10.1080/00015458.2022.2078030] [Reference Citation Analysis]
3 Gönül Geyik Ö, Anichini G, Ulukaya E, Marra F, Raggi C. DNA Damage Response Inhibitors in Cholangiocarcinoma: Current Progress and Perspectives. Cells 2022;11:1463. [DOI: 10.3390/cells11091463] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
4 Wang SY, Jiang N, Zeng JP, Yu SQ, Xiao Y, Jin S. Characteristic of Perineural Invasion in Hilar Cholangiocarcinoma Based on Whole-Mount Histologic Large Sections of Liver. Front Oncol 2022;12:855615. [PMID: 35350570 DOI: 10.3389/fonc.2022.855615] [Reference Citation Analysis]
5 Cammann S, Karabulut S, DeTemple DE, Oldhafer F, Kulik U, Schroeter A, Vondran FWR, Klempnauer J, Kleine M, Timrott K, Beetz O. Antibiotic-Resistant Bacteria Colonizing the Bile Duct Are Associated with Increased Morbidity and Mortality after Resection of Extrahepatic Cholangiocarcinoma. Surg Infect (Larchmt) 2022. [PMID: 35172114 DOI: 10.1089/sur.2021.117] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Khan J, Ullah A, Matolo N, Waheed A, Nama N, Khan T, Tareen B, Khan Z, Singh SG, Cason FD. Klatskin Tumor in the Light of ICD-O-3: A Population-Based Clinical Outcome Study Involving 1,144 Patients from the Surveillance, Epidemiology, and End Result (SEER) Database (2001-2012). Cureus 2021;13:e18941. [PMID: 34815893 DOI: 10.7759/cureus.18941] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
7 Yilmaz S, Carr BI, Akbulut S. Can the Limits of Liver Transplantation Be Expanded in Perihilar Cholangiocarcinoma? J Gastrointest Cancer 2021. [PMID: 34738188 DOI: 10.1007/s12029-021-00735-6] [Reference Citation Analysis]
8 Abdelrahim M, Esmail A, Abudayyeh A, Murakami N, Saharia A, McMillan R, Victor D, Kodali S, Shetty A, Nolte Fong JV, Moore LW, Heyne K, Gaber AO, Ghobrial RM. Transplant Oncology: An Evolving Field in Cancer Care. Cancers (Basel) 2021;13:4911. [PMID: 34638395 DOI: 10.3390/cancers13194911] [Cited by in F6Publishing: 11] [Reference Citation Analysis]
9 Rodriguez RR, Abel S, Mamadgi J, Renz PB, Wegner RE, Raj MS. Analysis of Post-operative Adjuvant Chemotherapy Versus Adjuvant Chemoradiation Therapy Outcomes in Non-metastatic Cholangiocarcinoma: an NCDB Review. J Gastrointest Cancer 2021. [PMID: 34486086 DOI: 10.1007/s12029-021-00696-w] [Reference Citation Analysis]
10 Wan T, Tu H, Liu L, Huang H, Feng Y, Liu J. Perineural Invasion Should Be Regarded as an Intermediate-Risk Factor for Recurrence in Surgically Treated Cervical Cancer: A Propensity Score Matching Study. Dis Markers 2021;2021:1375123. [PMID: 34394773 DOI: 10.1155/2021/1375123] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
11 Lauterio A, De Carlis R, Centonze L, Buscemi V, Incarbone N, Vella I, De Carlis L. Current Surgical Management of Peri-Hilar and Intra-Hepatic Cholangiocarcinoma. Cancers (Basel) 2021;13:3657. [PMID: 34359560 DOI: 10.3390/cancers13153657] [Cited by in Crossref: 1] [Cited by in F6Publishing: 15] [Article Influence: 1.0] [Reference Citation Analysis]
12 Narayan P, Flynn J, Zhang Z, Gillespie EF, Mueller B, Xu AJ, Cuaron J, McCormick B, Khan AJ, Cahlon O, Powell SN, Wen H, Braunstein LZ. Perineural invasion as a risk factor for locoregional recurrence of invasive breast cancer. Sci Rep 2021;11:12781. [PMID: 34140615 DOI: 10.1038/s41598-021-92343-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
13 Gao Z, Cao H, Xu X, Wang Q, Wu Y, Lu Q. Prognostic value of lymphovascular invasion in stage II colorectal cancer patients with an inadequate examination of lymph nodes. World J Surg Oncol 2021;19:125. [PMID: 33866973 DOI: 10.1186/s12957-021-02224-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
14 Lee SH, Choi GH, Han DH, Kim KS, Choi JS, Rho SY. Chronological analysis of surgical and oncological outcomes after the treatment of perihilar cholangiocarcinoma. Ann Hepatobiliary Pancreat Surg 2021;25:62-70. [PMID: 33649256 DOI: 10.14701/ahbps.2021.25.1.62] [Reference Citation Analysis]
15 Moreau J, Lapeyre M, Benoit C, Pezet D, Biau J. [Intra and extra hepatic cholangiocarcinomas radiation therapy]. Cancer Radiother 2021;25:175-81. [PMID: 33423966 DOI: 10.1016/j.canrad.2020.06.039] [Reference Citation Analysis]
16 She WH, Cheung TT, Ma KW, Tsang SHY, Dai WC, Chan ACY, Lo CM. Defining the optimal bilirubin level before hepatectomy for hilar cholangiocarcinoma. BMC Cancer 2020;20:914. [PMID: 32967634 DOI: 10.1186/s12885-020-07385-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
17 Chen L, Lin J, Chen LZ, Chen Y, Wang XJ, Guo ZQ, Yu JM. Perineural Invasion and Postoperative Complications are Independent Predictors of Early Recurrence and Survival Following Curative Resection of Gastric Cancer. Cancer Manag Res 2020;12:7601-10. [PMID: 32904660 DOI: 10.2147/CMAR.S264582] [Cited by in Crossref: 1] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
18 Takahashi H, Katsuta E, Yan L, Tokumaru Y, Katz MHG, Takabe K. Transcriptomic Profile of Lymphovascular Invasion, a Known Risk Factor of Pancreatic Ductal Adenocarcinoma Metastasis. Cancers (Basel) 2020;12:E2033. [PMID: 32722116 DOI: 10.3390/cancers12082033] [Cited by in Crossref: 7] [Cited by in F6Publishing: 12] [Article Influence: 3.5] [Reference Citation Analysis]
19 Teng F, Tang YY, Dai JL, Li Y, Chen ZY. The effect and safety of preoperative biliary drainage in patients with hilar cholangiocarcinoma: an updated meta-analysis. World J Surg Oncol 2020;18:174. [PMID: 32682432 DOI: 10.1186/s12957-020-01904-w] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
20 Li CG, Zhou ZP, Tan XL, Zhao ZM. Perineural invasion of hilar cholangiocarcinoma in Chinese population: One center’s experience. World J Gastrointest Oncol 2020; 12(4): 457-466 [PMID: 32368323 DOI: 10.4251/wjgo.v12.i4.457] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
21 Mehrabi A, Khajeh E, Ghamarnejad O, Nikdad M, Chang D, Büchler MW, Hoffmann K. Meta-analysis of the efficacy of preoperative biliary drainage in patients undergoing liver resection for perihilar cholangiocarcinoma. European Journal of Radiology 2020;125:108897. [DOI: 10.1016/j.ejrad.2020.108897] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
22 Jo HS, Kim DS, Yu YD, Kang WH, Yoon KC. Right-side versus left-side hepatectomy for the treatment of hilar cholangiocarcinoma: a comparative study. World J Surg Oncol 2020;18:3. [PMID: 31901228 DOI: 10.1186/s12957-019-1779-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
23 Lamarca A, Edeline J, McNamara MG, Hubner RA, Nagino M, Bridgewater J, Primrose J, Valle JW. Current standards and future perspectives in adjuvant treatment for biliary tract cancers. Cancer Treat Rev. 2020;84:101936. [PMID: 31986437 DOI: 10.1016/j.ctrv.2019.101936] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 7.7] [Reference Citation Analysis]
24 Huang T, Wang Y, Wang Z, Cui Y, Sun X, Wang Y. Weighted Gene Co-Expression Network Analysis Identified Cancer Cell Proliferation as a Common Phenomenon During Perineural Invasion. Onco Targets Ther 2019;12:10361-74. [PMID: 31819519 DOI: 10.2147/OTT.S229852] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
25 He M, Xu X, Feng H, Chen W, Liu H, Zhang Y, Wang J, Geng Z, Qiu Y, Duan W, Li X, Zhi X, Zhu W, Li F, Li J, Li S, He Y, Quan Z, Wang J. Regional lymphadenectomy vs. extended lymphadenectomy for hilar cholangiocarcinoma (Relay-HC trial): study protocol for a prospective, multicenter, randomized controlled trial. Trials 2019;20:528. [PMID: 31443731 DOI: 10.1186/s13063-019-3605-z] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
26 Tibana TK, Grubert RM, Fornazari VAV, Barbosa FCP, Bacelar B, Oliveira AF, Marchiori E, Nunes TF. The role of percutaneous transhepatic biliary biopsy in the diagnosis of patients with obstructive jaundice: an initial experience. Radiol Bras 2019;52:222-8. [PMID: 31435082 DOI: 10.1590/0100-3984.2018.0073] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
27 Zhang X, Liu H. Klatskin Tumor: A Population-Based Study of Incidence and Survival. Med Sci Monit 2019;25:4503-12. [PMID: 31204730 DOI: 10.12659/MSM.914987] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
28 Zhu Y, Zhang GN, Shi Y, Cui L, Leng XF, Huang JM. Perineural invasion in cervical cancer: pay attention to the indications of nerve-sparing radical hysterectomy. Ann Transl Med 2019;7:203. [PMID: 31205921 DOI: 10.21037/atm.2019.04.35] [Cited by in Crossref: 3] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
29 Hruban RH, Gaida MM, Thompson E, Hong SM, Noë M, Brosens LA, Jongepier M, Offerhaus GJA, Wood LD. Why is pancreatic cancer so deadly? The pathologist's view. J Pathol 2019;248:131-41. [PMID: 30838636 DOI: 10.1002/path.5260] [Cited by in Crossref: 25] [Cited by in F6Publishing: 37] [Article Influence: 8.3] [Reference Citation Analysis]
30 Wronka KM, Grąt M, Stypułkowski J, Bik E, Patkowski W, Krawczyk M, Zieniewicz K. Relevance of Preoperative Hyperbilirubinemia in Patients Undergoing Hepatobiliary Resection for Hilar Cholangiocarcinoma. J Clin Med 2019;8:E458. [PMID: 30959757 DOI: 10.3390/jcm8040458] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
31 Wang Y, Fu W, Tang Z, Meng W, Zhou W, Li X. Effect of preoperative cholangitis on prognosis of patients with hilar cholangiocarcinoma: A systematic review and meta-analysis. Medicine (Baltimore) 2018;97:e12025. [PMID: 30142851 DOI: 10.1097/MD.0000000000012025] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
32 Hester C, Nassour I, Adams-huet B, Augustine M, Choti MA, Minter RM, Mansour JC, Polanco PM, Porembka MR, Wang SC, Yopp AC. Improved Survival in Surgically Resected Distal Cholangiocarcinoma Treated with Adjuvant Therapy: a Propensity Score Matched Analysis. J Gastrointest Surg 2018;22:2080-7. [DOI: 10.1007/s11605-018-3875-x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
33 Quinn LM, Dunne DFJ, Jones RP, Poston GJ, Malik HZ, Fenwick SW. Optimal perioperative care in peri-hilar cholangiocarcinoma resection. Eur Surg 2018;50:93-9. [PMID: 29875797 DOI: 10.1007/s10353-018-0529-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
34 Naito Y, Kawahara A, Okabe Y, Ishida Y, Sadashima E, Murata K, Takase Y, Abe H, Yamaguchi T, Tanigawa M, Mihara Y, Kondo R, Kusano H, Nakayama M, Shimamatsu K, Yano H, Akiba J. SurePath® LBC improves the diagnostic accuracy of intrahepatic and hilar cholangiocarcinoma. Cytopathology 2018;29:349-54. [PMID: 29723910 DOI: 10.1111/cyt.12565] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
35 Zhu Y, Zhang G, Yang Y, Cui L, Jia S, Shi Y, Song S, Xu S. Perineural invasion in early-stage cervical cancer and its relevance following surgery. Oncol Lett 2018;15:6555-61. [PMID: 29755594 DOI: 10.3892/ol.2018.8116] [Cited by in Crossref: 4] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
36 Lee EC, Park SJ, Han SS, Shim JR, Park HM, Lee SD, Kim SH. Risk prediction of post-hepatectomy liver failure in patients with perihilar cholangiocarcinoma. J Gastroenterol Hepatol. 2018;33:958-965. [PMID: 28843035 DOI: 10.1111/jgh.13966] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 2.8] [Reference Citation Analysis]
37 Hu HJ, Zhou RX, Shrestha A, Tan YQ, Ma WJ, Yang Q, Lu J, Wang JK, Zhou Y, Li FY. Relationship of tumor size with pathological and prognostic factors for hilar cholangiocarcinoma. Oncotarget 2017;8:105011-9. [PMID: 29285229 DOI: 10.18632/oncotarget.22054] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
38 Wu CC. Progress of liver resection for hepatocellular carcinoma in Taiwan. Jpn J Clin Oncol 2017;47:375-80. [PMID: 28159964 DOI: 10.1093/jjco/hyx007] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
39 Celotti A, Solaini L, Montori G, Coccolini F, Tognali D, Baiocchi G. Preoperative biliary drainage in hilar cholangiocarcinoma: Systematic review and meta-analysis. Eur J Surg Oncol. 2017;43:1628-1635. [PMID: 28477976 DOI: 10.1016/j.ejso.2017.04.001] [Cited by in Crossref: 36] [Cited by in F6Publishing: 28] [Article Influence: 7.2] [Reference Citation Analysis]
40 Nantajit D, Trirussapanich P, Rojwatkarnjana S, Soonklang K, Pattaranutraporn P, Laebua K, Chamchod S. Clinical analysis of cholangiocarcinoma patients receiving adjuvant radiotherapy. Mol Clin Oncol 2016;5:797-802. [PMID: 28105359 DOI: 10.3892/mco.2016.1072] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
41 Li Z, Li TF, Ren JZ, Li WC, Ren JL, Shui SF, Han XW. Value of percutaneous transhepatic cholangiobiopsy for pathologic diagnosis of obstructive jaundice: analysis of 826 cases. Acta Radiol 2017;58:3-9. [PMID: 26917786 DOI: 10.1177/0284185116632386] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.2] [Reference Citation Analysis]
42 Horgan A, Knox J, Aneja P, Le L, McKeever E, McNamara M. Patterns of care and treatment outcomes in older patients with biliary tract cancer. Oncotarget 2015;6:44995-5004. [PMID: 26575326 DOI: 10.18632/oncotarget.5707] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.3] [Reference Citation Analysis]
43 Wang S, Tian F, Zhao X, Li D, He Y, Li Z, Chen J. A New Surgical Procedure "Dumbbell-Form Resection" for Selected Hilar Cholangiocarcinomas With Severe Jaundice: Comparison With Hemihepatectomy. Medicine (Baltimore) 2016;95:e2456. [PMID: 26765439 DOI: 10.1097/MD.0000000000002456] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
44 Amit M, Na'ara S, Gil Z. Mechanisms of cancer dissemination along nerves. Nat Rev Cancer. 2016;16:399-408. [PMID: 27150016 DOI: 10.1038/nrc.2016.38] [Cited by in Crossref: 90] [Cited by in F6Publishing: 118] [Article Influence: 15.0] [Reference Citation Analysis]
45 Hameed A, Pang T, Chiou J, Pleass H, Lam V, Hollands M, Johnston E, Richardson A, Yuen L. Percutaneous vs. endoscopic pre-operative biliary drainage in hilar cholangiocarcinoma - a systematic review and meta-analysis. HPB (Oxford) 2016;18:400-10. [PMID: 27154803 DOI: 10.1016/j.hpb.2016.03.002] [Cited by in Crossref: 47] [Cited by in F6Publishing: 47] [Article Influence: 7.8] [Reference Citation Analysis]
46 Esnaola NF, Meyer JE, Karachristos A, Maranki JL, Camp ER, Denlinger CS. Evaluation and management of intrahepatic and extrahepatic cholangiocarcinoma. Cancer. 2016;122:1349-1369. [PMID: 26799932 DOI: 10.1002/cncr.29692] [Cited by in Crossref: 97] [Cited by in F6Publishing: 128] [Article Influence: 16.2] [Reference Citation Analysis]
47 Neagos HC, Graur F, Neagos OE, Dumitrascu DI, Mihaileanu F, Vlad L. The multimodal treatment of central and peripheral cholangiocarcinoma - analysis based on a single center experience. Clujul Med 2015;88:203-7. [PMID: 26528072 DOI: 10.15386/cjmed-430] [Reference Citation Analysis]
48 Bhat M, Hathcock M, Kremers WK, Darwish Murad S, Schmit G, Martenson J, Alberts S, Rosen CB, Gores GJ, Heimbach J. Portal vein encasement predicts neoadjuvant therapy response in liver transplantation for perihilar cholangiocarcinoma protocol. Transpl Int 2015;28:1383-91. [DOI: 10.1111/tri.12640] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
49 Baheti AD, Tirumani SH, Shinagare AB, Rosenthal MH, Hornick JL, Ramaiya NH, Wolpin BM. Correlation of CT patterns of primary intrahepatic cholangiocarcinoma at the time of presentation with the metastatic spread and clinical outcomes: retrospective study of 92 patients. Abdom Imaging. 2014;39:1193-1201. [PMID: 24869789 DOI: 10.1007/s00261-014-0167-0] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.7] [Reference Citation Analysis]
50 Umeda J, Itoi T. Current status of preoperative biliary drainage. J Gastroenterol 2015;50:940-54. [DOI: 10.1007/s00535-015-1096-6] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 2.9] [Reference Citation Analysis]
51 Bertani H, Frazzoni M, Mangiafico S, Caruso A, Manno M, Mirante VG, Pigò F, Barbera C, Manta R, Conigliaro R. Cholangiocarcinoma and malignant bile duct obstruction: A review of last decades advances in therapeutic endoscopy. World J Gastrointest Endosc 2015; 7(6): 582-592 [PMID: 26078827 DOI: 10.4253/wjge.v7.i6.582] [Cited by in CrossRef: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
52 Poruk KE, Pawlik TM, Weiss MJ. Perioperative Management of Hilar Cholangiocarcinoma. J Gastrointest Surg 2015;19:1889-99. [PMID: 26022776 DOI: 10.1007/s11605-015-2854-8] [Cited by in Crossref: 40] [Cited by in F6Publishing: 43] [Article Influence: 5.7] [Reference Citation Analysis]
53 Hoehn RS, Wima K, Ertel AE, Meier A, Ahmad SA, Shah SA, Abbott DE. Adjuvant Chemotherapy and Radiation Therapy is Associated with Improved Survival for Patients with Extrahepatic Cholangiocarcinoma. Ann Surg Oncol. 2015;22 Suppl 3:S1133-S1139. [PMID: 25976862 DOI: 10.1245/s10434-015-4599-8] [Cited by in Crossref: 20] [Cited by in F6Publishing: 26] [Article Influence: 2.9] [Reference Citation Analysis]
54 Ting C, Huang W, Feng C, Yu C, Peng C, Su W, Lai H, Cheng K, Chuang P, Kao J. Clinical factors associated with the survival of patients with intrahepatic cholangiocarcinoma. Advances in Digestive Medicine 2016;3:11-7. [DOI: 10.1016/j.aidm.2014.12.004] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
55 Wu JQ, Wang H, Cui YF. Preoperative biliary drainage and pancreaticoduodenectomy. Shijie Huaren Xiaohua Zazhi 2015; 23(10): 1592-1596 [DOI: 10.11569/wcjd.v23.i10.1592] [Reference Citation Analysis]
56 Yashima Y, Sato S, Kawai T, Sugimoto T, Sato T, Kanda M, Obi S. Intraarterial 5-fluorouracil and interferon therapy is safe and effective for nonresectable biliary tract adenocarcinoma. Hepatol Int 2015;9:142-8. [PMID: 25788388 DOI: 10.1007/s12072-014-9583-z] [Cited by in Crossref: 2] [Article Influence: 0.3] [Reference Citation Analysis]
57 Cui L, Shi Y, Zhang GN. Perineural invasion as a prognostic factor for cervical cancer: a systematic review and meta-analysis. Arch Gynecol Obstet 2015;292:13-9. [PMID: 25637504 DOI: 10.1007/s00404-015-3627-z] [Cited by in Crossref: 21] [Cited by in F6Publishing: 31] [Article Influence: 3.0] [Reference Citation Analysis]
58 Kimura N, Toyoki Y, Ishido K, Kudo D, Yakoshi Y, Tsutsumi S, Miura T, Wakiya T, Hakamada K. Perioperative blood transfusion as a poor prognostic factor after aggressive surgical resection for hilar cholangiocarcinoma. J Gastrointest Surg 2015;19:866-79. [PMID: 25605416 DOI: 10.1007/s11605-014-2741-8] [Cited by in Crossref: 10] [Cited by in F6Publishing: 17] [Article Influence: 1.4] [Reference Citation Analysis]
59 Cho CS. Prognostication systems as applied to primary and metastatic hepatic malignancies. Surg Oncol Clin N Am 2015;24:41-56. [PMID: 25444468 DOI: 10.1016/j.soc.2014.09.010] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
60 Xiong J, Nunes QM, Huang W, Wei A, Ke N, Mai G, Liu X, Hu W. Major hepatectomy in Bismuth types I and II hilar cholangiocarcinoma. J Surg Res. 2015;194:194-201. [PMID: 25454973 DOI: 10.1016/j.jss.2014.10.029] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 2.3] [Reference Citation Analysis]
61 Wang Y, Duan B, Yan L, Shen C, Wu B, Luo J, Shen F, Zhao G. Long-term outcome after surgical resection for cholangiocarcinoma and prognostic index value. Surgeon 2016;14:38-43. [PMID: 25263386 DOI: 10.1016/j.surge.2014.05.003] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
62 Nakashima S, Kobayashi S, Sakai D, Tomokuni A, Tomimaru Y, Hama N, Wada H, Kawamoto K, Marubashi S, Eguchi H. Prognostic impact of tumoral and/or peri-tumoral stromal SPARC expressions after surgery in patients with biliary tract cancer. J Surg Oncol. 2014;110:1016-1022. [PMID: 25155283 DOI: 10.1002/jso.23767] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
63 Zhang W, Yan LN. Perihilar cholangiocarcinoma: Current therapy. World J Gastrointest Pathophysiol 2014; 5(3): 344-354 [PMID: 25133034 DOI: 10.4291/wjgp.v5.i3.344] [Cited by in CrossRef: 23] [Cited by in F6Publishing: 17] [Article Influence: 2.9] [Reference Citation Analysis]
64 Skipworth JR, Keane MG, Pereira SP. Update on the management of cholangiocarcinoma. Dig Dis 2014;32:570-8. [PMID: 25034290 DOI: 10.1159/000360507] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 2.4] [Reference Citation Analysis]
65 Koo TR, Eom KY, Kim IA, Cho JY, Yoon YS, Hwang DW, Han HS, Kim JS. Patterns of failure and prognostic factors in resected extrahepatic bile duct cancer: implication for adjuvant radiotherapy. Radiat Oncol J. 2014;32:63-69. [PMID: 25061574 DOI: 10.3857/roj.2014.32.2.63] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 2.4] [Reference Citation Analysis]
66 Mattiucci GC, Autorino R, D’agostino GR, Deodato F, Macchia G, Perri V, Tringali A, Morganti AG, Mutignani M, Valentini V. Chemoradiation and brachytherapy in extrahepatic bile duct carcinoma. Critical Reviews in Oncology/Hematology 2014;90:58-67. [DOI: 10.1016/j.critrevonc.2013.10.007] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.5] [Reference Citation Analysis]
67 Paik WH, Loganathan N, Hwang JH. Preoperative biliary drainage in hilar cholangiocarcinoma: When and how? World J Gastrointest Endosc 2014; 6(3): 68-73 [PMID: 24634710 DOI: 10.4253/wjge.v6.i3.68] [Cited by in CrossRef: 32] [Cited by in F6Publishing: 26] [Article Influence: 4.0] [Reference Citation Analysis]
68 Xiong JJ, Nunes QM, Huang W, Pathak S, Wei AL, Tan CL, Liu XB. Preoperative biliary drainage in patients with hilar cholangiocarcinoma undergoing major hepatectomy. World J Gastroenterol 2013; 19(46): 8731-8739 [PMID: 24379593 DOI: 10.3748/wjg.v19.i46.8731] [Cited by in CrossRef: 20] [Cited by in F6Publishing: 22] [Article Influence: 2.2] [Reference Citation Analysis]
69 Nanashima A, Abo T, Murakami G, Matsumoto A, Tou K, Takeshita H, Kunizaki M, Hidaka S, Sakamoto I, Hayashi H. Intrahepatic cholangiocarcinoma: relationship between tumor imaging enhancement by measuring attenuation and clinicopathologic characteristics. Abdom Imaging. 2013;38:785-792. [PMID: 23232581 DOI: 10.1007/s00261-012-9974-3] [Cited by in Crossref: 28] [Cited by in F6Publishing: 26] [Article Influence: 3.1] [Reference Citation Analysis]
70 Webb K, Saunders M. Endoscopic management of malignant bile duct strictures. Gastrointest Endosc Clin N Am. 2013;23:313-331. [PMID: 23540963 DOI: 10.1016/j.giec.2012.12.009] [Cited by in Crossref: 19] [Cited by in F6Publishing: 13] [Article Influence: 2.1] [Reference Citation Analysis]
71 Li TF, Ren KW, Han XW, Li WC, Ren JL, Jiao DC, Li Z, Ma J. Percutaneous transhepatic cholangiobiopsy to determine the pathological cause of anastomotic stenosis after cholangiojejunostomy for malignant obstructive jaundice. Clin Radiol 2014;69:13-7. [PMID: 24156795 DOI: 10.1016/j.crad.2013.05.096] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 1.2] [Reference Citation Analysis]
72 Serrablo A, Tejedor L. Outcome of surgical resection in Klatskin tumors. World J Gastrointest Oncol 2013; 5(7): 147-158 [PMID: 23919109 DOI: 10.4251/wjgo.v5.i7.147] [Cited by in CrossRef: 16] [Cited by in F6Publishing: 17] [Article Influence: 1.8] [Reference Citation Analysis]
73 Wirasorn K, Ngamprasertchai T, Chindaprasirt J, Sookprasert A, Khantikaew N, Pakkhem A, Ungarereevittaya P. Prognostic factors in resectable cholangiocarcinoma patients: Carcinoembryonic antigen, lymph node, surgical margin and chemotherapy. World J Gastrointest Oncol 2013; 5(4): 81-87 [PMID: 23671735 DOI: 10.4251/wjgo.v5.i4.81] [Cited by in CrossRef: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
74 Iacono C, Ruzzenente A, Campagnaro T, Bortolasi L, Valdegamberi A, Guglielmi A. Role of preoperative biliary drainage in jaundiced patients who are candidates for pancreatoduodenectomy or hepatic resection: highlights and drawbacks. Ann Surg. 2013;257:191-204. [PMID: 23013805 DOI: 10.1097/sla.0b013e31826f4b0e] [Cited by in Crossref: 107] [Cited by in F6Publishing: 107] [Article Influence: 11.9] [Reference Citation Analysis]
75 Romiti A, D’Antonio C, Zullo A, Sarcina I, Di Rocco R, Barucca V, Durante V, Marchetti P. Chemotherapy for the biliary tract cancers: moving toward improved survival time. J Gastrointest Cancer. 2012;43:396-404. [PMID: 22328060 DOI: 10.1007/s12029-012-9369-2] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 1.9] [Reference Citation Analysis]
76 Izbicki JR, Tsui TY, Bohn BA, Bockhorn M. Surgical strategies in patients with advanced hilar cholangiocarcinoma (Klatskin tumor). J Gastrointest Surg 2013;17:581-5. [PMID: 23242846 DOI: 10.1007/s11605-012-2109-x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
77 Izquierdo F, Suárez-vilela D, Honrado E. Perineurial Cells in Granular Cell Tumors and Neoplasms With Perineural Invasion: An Immunohistochemical Study. The American Journal of Dermatopathology 2012;34:800-9. [DOI: 10.1097/dad.0b013e31824ba93b] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
78 Wadsworth CA, Lim A, Taylor-robinson SD, Khan SA. The risk factors and diagnosis of cholangiocarcinoma. Hepatol Int 2013;7:377-93. [DOI: 10.1007/s12072-012-9407-y] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
79 Lee BS, Hwang JH, Lee SH, Jang SE, Ahn DW, Hwang DW, Cho JY, Yoon YS, Han HS, Ahn S. Older adults with biliary tract cancer: treatment and prognosis. J Am Geriatr Soc 2012;60:1862-71. [PMID: 23035728 DOI: 10.1111/j.1532-5415.2012.04163.x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
80 Barton JG, Barrett DA, Maricevich MA, Schnelldorfer T, Wood CM, Smyrk TC, Baron TH, Sarr MG, Donohue JH, Farnell MB. Intraductal papillary mucinous neoplasm of the biliary tract: a real disease? HPB (Oxford). 2009;11:684-691. [PMID: 20495637 DOI: 10.1111/j.1477-2574.2009.00122.x] [Cited by in Crossref: 49] [Cited by in F6Publishing: 52] [Article Influence: 4.9] [Reference Citation Analysis]
81 Berardi R, Mocchegiani F, Pierantoni C, Federici A, Nicolini D, Morgese F, Onofri A, Risaliti A, Vivarelli M, Cascinu S. Resected biliary tract cancers: a novel clinical-pathological score correlates with global outcome. Dig Liver Dis 2013;45:70-4. [PMID: 22999058 DOI: 10.1016/j.dld.2012.08.012] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
82 Singh MK, Facciuto ME. Current management of cholangiocarcinoma. Mt Sinai J Med. 2012;79:232-245. [PMID: 22499494 DOI: 10.1002/msj.21298] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
83 Horino K, Beppu T, Kuroki H, Mima K, Okabe H, Nakahara O, Ikuta Y, Chikamoto A, Ishiko T, Takamori H, Baba H. Glasgow Prognostic Score as a useful prognostic factor after hepatectomy for hepatocellular carcinoma. Int J Clin Oncol 2013;18:829-38. [DOI: 10.1007/s10147-012-0451-3] [Cited by in Crossref: 24] [Cited by in F6Publishing: 28] [Article Influence: 2.4] [Reference Citation Analysis]
84 Darwish Murad S, Kim WR, Harnois DM, Douglas DD, Burton J, Kulik LM, Botha JF, Mezrich JD, Chapman WC, Schwartz JJ, Hong JC, Emond JC, Jeon H, Rosen CB, Gores GJ, Heimbach JK. Efficacy of neoadjuvant chemoradiation, followed by liver transplantation, for perihilar cholangiocarcinoma at 12 US centers. Gastroenterology 2012; 143: 88-98. quiz e14. [PMID: 22504095 DOI: 10.1053/j.gastro.2012.04.008] [Cited by in Crossref: 311] [Cited by in F6Publishing: 320] [Article Influence: 31.1] [Reference Citation Analysis]
85 Yusoff AR, Abdul Razak MM, Yoong BK, Vijeyasingam R, Siti ZM. Survival analysis of cholangiocarcinoma: A 10-year experience in Malaysia. World J Gastroenterol 2012; 18(5): 458-465 [PMID: 22346252 DOI: 10.3748/wjg.v18.i5.458] [Cited by in CrossRef: 16] [Cited by in F6Publishing: 13] [Article Influence: 1.6] [Reference Citation Analysis]
86 Ribero D, Amisano M, Lo Tesoriere R, Rosso S, Ferrero A, Capussotti L. Additional resection of an intraoperative margin-positive proximal bile duct improves survival in patients with hilar cholangiocarcinoma. Ann Surg. 2011;254:776-81; discussion 781-3. [PMID: 22042470 DOI: 10.1097/sla.0b013e3182368f85] [Cited by in Crossref: 63] [Cited by in F6Publishing: 68] [Article Influence: 6.3] [Reference Citation Analysis]
87 Paul A, Kaiser GM, Molmenti EP, Schroeder T, Vernadakis S, Oezcelik A, Baba HA, Cicinnati VR, Sotiropoulos GC. Klatskin Tumors and the Accuracy of the Bismuth-Corlette Classification. The American Surgeon 2011;77:1695-9. [DOI: 10.1177/000313481107701246] [Cited by in Crossref: 26] [Cited by in F6Publishing: 10] [Article Influence: 2.4] [Reference Citation Analysis]
88 Bapat AA, Hostetter G, Von Hoff DD, Han H. Perineural invasion and associated pain in pancreatic cancer. Nat Rev Cancer 2011;11:695-707. [DOI: 10.1038/nrc3131] [Cited by in Crossref: 207] [Cited by in F6Publishing: 223] [Article Influence: 18.8] [Reference Citation Analysis]
89 Skipworth JR, Olde Damink SW, Imber C, Bridgewater J, Pereira SP, Malagó M. Review article: surgical, neo-adjuvant and adjuvant management strategies in biliary tract cancer. Aliment Pharmacol Ther. 2011;34:1063-1078. [PMID: 21933219 DOI: 10.1111/j.1365-2036.2011.04851.x] [Cited by in Crossref: 63] [Cited by in F6Publishing: 62] [Article Influence: 5.7] [Reference Citation Analysis]
90 Hemming AW, Mekeel K, Khanna A, Baquerizo A, Kim RD. Portal vein resection in management of hilar cholangiocarcinoma. J Am Coll Surg 2011;212:604-13; discussion 613-6. [PMID: 21463797 DOI: 10.1016/j.jamcollsurg.2010.12.028] [Cited by in Crossref: 59] [Cited by in F6Publishing: 61] [Article Influence: 5.4] [Reference Citation Analysis]
91 Zografos GN, Farfaras A, Zagouri F, Chrysikos D, Karaliotas K. Cholangiocarcinoma: principles and current trends. Hepatobiliary Pancreat Dis Int 2011;10:10-20. [PMID: 21269929 DOI: 10.1016/s1499-3872(11)60001-5] [Cited by in Crossref: 34] [Cited by in F6Publishing: 29] [Article Influence: 3.1] [Reference Citation Analysis]
92 Oh I, Kim S, Ha K. Significant predictive values for the life expectancy in patients with spinal metastasis following surgical treatment. Eur J Orthop Surg Traumatol 2012;22:17-24. [DOI: 10.1007/s00590-011-0807-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
93 Mann CD, Palser T, Briggs CD, Cameron I, Rees M, Buckles J, Berry DP. A review of factors predicting perioperative death and early outcome in hepatopancreaticobiliary cancer surgery. HPB (Oxford) 2010;12:380-8. [PMID: 20662788 DOI: 10.1111/j.1477-2574.2010.00179.x] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 2.0] [Reference Citation Analysis]
94 Akamatsu N, Sugawara Y, Hashimoto D. Surgical strategy for bile duct cancer: Advances and current limitations. World J Clin Oncol 2011; 2(2): 94-107 [PMID: 21603318 DOI: 10.5306/wjco.v2.i2.94] [Cited by in CrossRef: 41] [Cited by in F6Publishing: 39] [Article Influence: 3.7] [Reference Citation Analysis]
95 Liu SL, Song ZF, Hu QG, Shan D, Hu SB, Li J, Zheng QC. Serum carbohydrate antigen (CA) 19-9 as a prognostic factor in cholangiocarcinoma: a meta-analysis. Front Med China. 2010;4:457-462. [PMID: 21191748 DOI: 10.1007/s11684-010-0240-1] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 1.6] [Reference Citation Analysis]
96 Izzo F, Piccirillo M, Albino V, Botti G, Foggia M, Iodice R, Pagano F, Piccirillo G, Tornillo L, Delrio P. Case report: appearance of an intestinal metastasis from intrahepatic cholangiocarcinoma occurring 5 years after resection of the primary tumor. Eur J Gastroenterol Hepatol 2010;22:892-4. [PMID: 19550345 DOI: 10.1097/MEG.0b013e32832eb62b] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
97 Yasuda Y, Larsen PN, Ishibashi T, Yamashita K, Toei H. Resection of hilar cholangiocarcinoma with left hepatectomy after pre-operative embolization of the proper hepatic artery. HPB (Oxford) 2010;12:147-52. [PMID: 20495660 DOI: 10.1111/j.1477-2574.2009.00152.x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
98 Liu F, Li Y, Wei Y, Li B. Preoperative biliary drainage before resection for hilar cholangiocarcinoma: whether or not? Dig Dis Sci. 2011;56:663-672. [PMID: 20635143 DOI: 10.1007/s10620-010-1338-7] [Cited by in Crossref: 74] [Cited by in F6Publishing: 65] [Article Influence: 6.2] [Reference Citation Analysis]
99 Kloek JJ, Ten Kate FJ, Busch OR, Gouma DJ, van Gulik TM. Surgery for extrahepatic cholangiocarcinoma: predictors of survival. HPB (Oxford) 2008;10:190-5. [PMID: 18773053 DOI: 10.1080/13651820801992575] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 2.0] [Reference Citation Analysis]
100 Capussotti L, Vigano L, Ferrero A, Muratore A. Local surgical resection of hilar cholangiocarcinoma: is there still a place? HPB (Oxford). 2008;10:174-178. [PMID: 18773049 DOI: 10.1080/13651820801992534] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 1.3] [Reference Citation Analysis]
101 Iida A, Yoshidome H, Shida T, Takano S, Takeuchi D, Kimura F, Shimizu H, Ohtsuka M, Miyazaki M. Hepatocyte nuclear factor-kappa beta (NF-kappaB) activation is protective but is decreased in the cholestatic liver with endotoxemia. Surgery 2010;148:477-89. [PMID: 20227101 DOI: 10.1016/j.surg.2010.01.014] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
102 Kobayashi A, Miwa S, Nakata T, Miyagawa S. Disease recurrence patterns after R0 resection of hilar cholangiocarcinoma. Br J Surg. 2010;97:56-64. [PMID: 19937985 DOI: 10.1002/bjs.6788] [Cited by in Crossref: 67] [Cited by in F6Publishing: 67] [Article Influence: 5.2] [Reference Citation Analysis]
103 Park J, Kim MH, Kim KP, Park DH, Moon SH, Song TJ, Eum J, Lee SS, Seo DW, Lee SK. Natural History and Prognostic Factors of Advanced Cholangiocarcinoma without Surgery, Chemotherapy, or Radiotherapy: A Large-Scale Observational Study. Gut Liver. 2009;3:298-305. [PMID: 20431764 DOI: 10.5009/gnl.2009.3.4.298] [Cited by in Crossref: 111] [Cited by in F6Publishing: 100] [Article Influence: 8.5] [Reference Citation Analysis]
104 Nguyen KT, Steel J, Vanounou T, Tsung A, Marsh JW, Geller DA, Gamblin TC. Initial presentation and management of hilar and peripheral cholangiocarcinoma: is a node-positive status or potential margin-positive result a contraindication to resection? Ann Surg Oncol 2009;16:3308-15. [PMID: 19774418 DOI: 10.1245/s10434-009-0701-4] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 2.1] [Reference Citation Analysis]
105 Aljiffry M, Walsh MJ, Molinari M. Advances in diagnosis, treatment and palliation of cholangiocarcinoma: 1990-2009. World J Gastroenterol 2009; 15(34): 4240-4262 [PMID: 19750567 DOI: 10.3748/wjg.15.4240] [Cited by in CrossRef: 180] [Cited by in F6Publishing: 165] [Article Influence: 13.8] [Reference Citation Analysis]
106 Liebig C, Ayala G, Wilks JA, Berger DH, Albo D. Perineural invasion in cancer: a review of the literature. Cancer. 2009;115:3379-3391. [PMID: 19484787 DOI: 10.1002/cncr.24396] [Cited by in Crossref: 493] [Cited by in F6Publishing: 547] [Article Influence: 37.9] [Reference Citation Analysis]
107 Ito F, Cho CS, Rikkers LF, Weber SM. Hilar cholangiocarcinoma: current management. Ann Surg. 2009;250:210-218. [PMID: 19638920 DOI: 10.1097/sla.0b013e3181afe0ab] [Cited by in Crossref: 153] [Cited by in F6Publishing: 139] [Article Influence: 11.8] [Reference Citation Analysis]
108 Nakanishi Y, Kondo S, Zen Y, Yonemori A, Kubota K, Kawakami H, Tanaka E, Hirano S, Itoh T, Nakanuma Y. Impact of residual in situ carcinoma on postoperative survival in 125 patients with extrahepatic bile duct carcinoma. Journal of Hepato-Biliary-Pancreatic Sciences 2010;17:166-73. [DOI: 10.1007/s00534-009-0127-1] [Cited by in Crossref: 39] [Cited by in F6Publishing: 32] [Article Influence: 3.0] [Reference Citation Analysis]
109 Iida A, Yoshidome H, Shida T, Kimura F, Shimizu H, Ohtsuka M, Morita Y, Takeuchi D, Miyazaki M. Does prolonged biliary obstructive jaundice sensitize the liver to endotoxemia? Shock. 2009;31:397-403. [PMID: 18665046 DOI: 10.1097/shk.0b013e31818349ea] [Cited by in Crossref: 15] [Cited by in F6Publishing: 20] [Article Influence: 1.2] [Reference Citation Analysis]
110 Murakami Y, Uemura K, Sudo T, Hayashidani Y, Hashimoto Y, Nakamura H, Nakashima A, Sueda T. Gemcitabine-based adjuvant chemotherapy improves survival after aggressive surgery for hilar cholangiocarcinoma. J Gastrointest Surg. 2009;13:1470-1479. [PMID: 19421824 DOI: 10.1007/s11605-009-0900-0] [Cited by in Crossref: 72] [Cited by in F6Publishing: 67] [Article Influence: 5.5] [Reference Citation Analysis]
111 Mosconi S, Beretta GD, Labianca R, Zampino MG, Gatta G, Heinemann V. Cholangiocarcinoma. Critical Reviews in Oncology/Hematology 2009;69:259-70. [DOI: 10.1016/j.critrevonc.2008.09.008] [Cited by in Crossref: 99] [Cited by in F6Publishing: 102] [Article Influence: 7.6] [Reference Citation Analysis]
112 Anderson C, Kim R. Adjuvant therapy for resected extrahepatic cholangiocarcinoma: a review of the literature and future directions. Cancer Treat Rev. 2009;35:322-327. [PMID: 19147294 DOI: 10.1016/j.ctrv.2008.11.009] [Cited by in Crossref: 39] [Cited by in F6Publishing: 42] [Article Influence: 3.0] [Reference Citation Analysis]
113 Nanashima A, Sumida Y, Abo T, Oikawa M, Murakami G, Takeshita H, Fukuoka H, Hidaka S, Nagayasu T, Sakamoto I. Relationship between pattern of tumor enhancement and clinicopathologic characteristics in intrahepatic cholangiocarcinoma. J Surg Oncol. 2008;98:535-539. [PMID: 18814285 DOI: 10.1002/jso.21142] [Cited by in Crossref: 36] [Cited by in F6Publishing: 33] [Article Influence: 2.8] [Reference Citation Analysis]
114 Briggs CD, Neal CP, Mann CD, Steward WP, Manson MM, Berry DP. Prognostic molecular markers in cholangiocarcinoma: a systematic review. Eur J Cancer. 2009;45:33-47. [PMID: 18938071 DOI: 10.1016/j.ejca.2008.08.024] [Cited by in Crossref: 67] [Cited by in F6Publishing: 59] [Article Influence: 4.8] [Reference Citation Analysis]
115 Ito F, Agni R, Rettammel RJ, Been MJ, Cho CS, Mahvi DM, Rikkers LF, Weber SM. Resection of hilar cholangiocarcinoma: concomitant liver resection decreases hepatic recurrence. Ann Surg. 2008;248:273-279. [PMID: 18650638 DOI: 10.1097/sla.0b013e31817f2bfd] [Cited by in Crossref: 120] [Cited by in F6Publishing: 116] [Article Influence: 8.6] [Reference Citation Analysis]
116 Kloek J, Marsman H, van Vliet A, Gouma D, van Gulik T. Biliary drainage attenuates postischemic reperfusion injury in the cholestatic rat liver. Surgery 2008;144:22-31. [DOI: 10.1016/j.surg.2008.03.030] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 1.6] [Reference Citation Analysis]
117 Regimbeau J, Fuks D, Chatelain D, Riboulot M, Delcenserie R, Yzet T. Prise en charge chirurgicale du cholangiocarcinome hilaire résécable. Gastroentérologie Clinique et Biologique 2008;32:620-31. [DOI: 10.1016/j.gcb.2008.04.027] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
118 Farhat MH, Shamseddine AI, Tawil AN, Berjawi G, Sidani C, Shamseddeen W, Barada KA. Prognostic factors in patients with advanced cholangiocarcinoma: Role of surgery, chemotherapy and body mass index. World J Gastroenterol 2008; 14(20): 3224-3230 [PMID: 18506930 DOI: 10.3748/wjg.14.3224] [Cited by in CrossRef: 14] [Cited by in F6Publishing: 16] [Article Influence: 1.0] [Reference Citation Analysis]
119 Konstadoulakis MM, Roayaie S, Gomatos IP, Labow D, Fiel MI, Miller CM, Schwartz ME. Aggressive surgical resection for hilar cholangiocarcinoma: is it justified? Audit of a single center’s experience. Am J Surg. 2008;196:160-169. [PMID: 18466862 DOI: 10.1016/j.amjsurg.2007.07.033] [Cited by in Crossref: 57] [Cited by in F6Publishing: 57] [Article Influence: 4.1] [Reference Citation Analysis]
120 Paik KY, Choi DW, Chung JC, Kang KT, Kim SB. Improved survival following right trisectionectomy with caudate lobectomy without operative mortality: surgical treatment for hilar cholangiocarcinoma. J Gastrointest Surg. 2008;12:1268-1274. [PMID: 18330655 DOI: 10.1007/s11605-008-0503-1] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 1.4] [Reference Citation Analysis]
121 Miyakawa S, Ishihara S, Takada T, Miyazaki M, Tsukada K, Nagino M, Kondo S, Furuse J, Saito H, Tsuyuguchi T. Flowcharts for the management of biliary tract and ampullary carcinomas. J Hepatobiliary Pancreat Surg. 2008;15:7-14. [PMID: 18274839 DOI: 10.1007/s00534-007-1275-9] [Cited by in Crossref: 17] [Cited by in F6Publishing: 20] [Article Influence: 1.2] [Reference Citation Analysis]
122 Kondo S, Takada T, Miyazaki M, Miyakawa S, Tsukada K, Nagino M, Furuse J, Saito H, Tsuyuguchi T, Yamamoto M, Kayahara M, Kimura F, Yoshitomi H, Nozawa S, Yoshida M, Wada K, Hirano S, Amano H, Miura F; Japanese Association of Biliary Surgery; Japanese Society of Hepato-Biliary-Pancreatic Surgery; Japan Society of Clinical Oncology. Guidelines for the management of biliary tract and ampullary carcinomas: surgical treatment. J Hepatobiliary Pancreat Surg. 2008;15:41-54. [PMID: 18274843 DOI: 10.1007/s00534-007-1279-5] [Cited by in Crossref: 137] [Cited by in F6Publishing: 134] [Article Influence: 9.8] [Reference Citation Analysis]
123 Junking M, Wongkham C, Sripa B, Sawanyawisuth K, Araki N, Wongkham S. Decreased expression of galectin-3 is associated with metastatic potential of liver fluke-associated cholangiocarcinoma. Eur J Cancer. 2008;44:619-626. [PMID: 18272359 DOI: 10.1016/j.ejca.2008.01.014] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 1.4] [Reference Citation Analysis]
124 Li CG, Huang ZQ, Wei LX, Dong JH, Liu JG, Wang YS. Clinical pathology of perineural invasion in hilar cholangiocarcinoma. Shijie Huaren Xiaohua Zazhi 2008; 16(4): 379-384 [DOI: 10.11569/wcjd.v16.i4.379] [Reference Citation Analysis]
125 Otani K, Chijiiwa K, Kai M, Ohuchida J, Nagano M, Tsuchiya K, Kondo K. Outcome of surgical treatment of hilar cholangiocarcinoma. J Gastrointest Surg. 2008;12:1033-1040. [PMID: 18085342 DOI: 10.1007/s11605-007-0453-z] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 1.7] [Reference Citation Analysis]
126 Hidalgo E, Asthana S, Nishio H, Wyatt J, Toogood GJ, Prasad KR, Lodge JP. Surgery for hilar cholangiocarcinoma: the Leeds experience. Eur J Surg Oncol. 2008;34:787-794. [PMID: 18036765 DOI: 10.1016/j.ejso.2007.10.005] [Cited by in Crossref: 83] [Cited by in F6Publishing: 74] [Article Influence: 5.5] [Reference Citation Analysis]
127 Chen RF, Li ZH, Zhou JJ, Wang J, Chen JS, Lin Q, Tang QB, Peng NF, Jiang ZP, Zhou QB. Preoperative evaluation with T-staging system for hilar cholangiocarcinoma. World J Gastroenterol 2007; 13(43): 5754-5759 [PMID: 17963304 DOI: 10.3748/wjg.v13.i43.5754] [Cited by in CrossRef: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
128 Masunari H, Shimada H, Endo I, Fujii Y, Tanaka K, Sekido H, Togo S. Surgical Anatomy of Hepatic Hilum with Special Reference of the Plate System and Extrahepatic Duct. J Gastrointest Surg 2008;12:1047-53. [DOI: 10.1007/s11605-007-0358-x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
129 Cleary SP, Dawson LA, Knox JJ, Gallinger S. Cancer of the gallbladder and extrahepatic bile ducts. Curr Probl Surg. 2007;44:396-482. [PMID: 17693325 DOI: 10.1067/j.cpsurg.2007.04.006] [Cited by in Crossref: 23] [Cited by in F6Publishing: 17] [Article Influence: 1.5] [Reference Citation Analysis]
130 Nathan H, Pawlik TM, Wolfgang CL, Choti MA, Cameron JL, Schulick RD. Trends in survival after surgery for cholangiocarcinoma: a 30-year population-based SEER database analysis. J Gastrointest Surg. 2007;11:1488-1496; discussion 1496-1497. [PMID: 17805937 DOI: 10.1007/s11605-007-0282-0] [Cited by in Crossref: 148] [Cited by in F6Publishing: 210] [Article Influence: 9.9] [Reference Citation Analysis]
131 Seubwai W, Wongkham C, Puapairoj A, Khuntikeo N, Wongkham S. Overexpression of vitamin D receptor indicates a good prognosis for cholangiocarcinoma: implications for therapeutics. Cancer 2007;109:2497-505. [PMID: 17487855 DOI: 10.1002/cncr.22716] [Cited by in Crossref: 27] [Cited by in F6Publishing: 29] [Article Influence: 1.8] [Reference Citation Analysis]
132 DeOliveira ML, Cunningham SC, Cameron JL, Kamangar F, Winter JM, Lillemoe KD, Choti MA, Yeo CJ, Schulick RD. Cholangiocarcinoma: thirty-one-year experience with 564 patients at a single institution. Ann Surg. 2007;245:755-762. [PMID: 17457168 DOI: 10.1097/01.sla.0000251366.62632] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
133 DeOliveira ML, Cunningham SC, Cameron JL, Kamangar F, Winter JM, Lillemoe KD, Choti MA, Yeo CJ, Schulick RD. Cholangiocarcinoma: thirty-one-year experience with 564 patients at a single institution. Ann Surg. 2007;245:755-762. [PMID: 17457168 DOI: 10.1097/01.sla.0000251366.62632.d3] [Cited by in Crossref: 777] [Cited by in F6Publishing: 765] [Article Influence: 51.8] [Reference Citation Analysis]
134 Seyama Y, Makuuchi M. Current surgical treatment for bile duct cancer. World J Gastroenterol 2007; 13(10): 1505-1515 [PMID: 17461441 DOI: 10.3748/wjg.v13.i10.1505] [Cited by in CrossRef: 88] [Cited by in F6Publishing: 76] [Article Influence: 5.9] [Reference Citation Analysis]
135 Nagorney DM, Kendrick ML. Hepatic resection in the treatment of hilar cholangiocarcinoma. Adv Surg. 2006;40:159-171. [PMID: 17163100 DOI: 10.1016/j.yasu.2006.05.009] [Cited by in Crossref: 46] [Cited by in F6Publishing: 41] [Article Influence: 3.1] [Reference Citation Analysis]
136 Slattery JM, Sahani DV. What is the current state-of-the-art imaging for detection and staging of cholangiocarcinoma? Oncologist. 2006;11:913-922. [PMID: 16951395 DOI: 10.1634/theoncologist.11-8-913] [Cited by in Crossref: 68] [Cited by in F6Publishing: 49] [Article Influence: 4.3] [Reference Citation Analysis]
137 Nagino M, Nishio H, Ebata T, Yokoyama Y, Igami T, Nimura Y. Intrahepatic cholangiojejunostomy following hepatobiliary resection. British Journal of Surgery 2007;94:70-7. [DOI: 10.1002/bjs.5531] [Cited by in Crossref: 46] [Cited by in F6Publishing: 42] [Article Influence: 2.9] [Reference Citation Analysis]
138 Gerhardt T, Milz S, Schepke M, Feldmann G, Wolff M, Sauerbruch T, Dumoulin FL. C-reactive protein is a prognostic indicator in patients with perihilar cholangiocarcinoma. World J Gastroenterol 2006; 12(34): 5495-5500 [PMID: 17006987 DOI: 10.3748/wjg.v12.i34.5495] [Cited by in CrossRef: 40] [Cited by in F6Publishing: 37] [Article Influence: 2.5] [Reference Citation Analysis]
139 Park JY, Park SW, Chung JB, Seong J, Kim KS, Lee WJ, Song SY. Concurrent Chemoradiotherapy With Doxifluridine and Paclitaxel for Extrahepatic Bile Duct Cancer. American Journal of Clinical Oncology 2006;29:240-5. [DOI: 10.1097/01.coc.0000217829.77404.22] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
140 Veroux M, Madia C, Fiamingo P, Caglià P, Valastro M, Amodeo C, Veroux P, Gagliano M, Basso S, D'Amico DF. Could a high resectability rate improve the long-term survival of patients with proximal bile duct cancer? J Surg Oncol 2006;93:199-205. [PMID: 16482599 DOI: 10.1002/jso.20256] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
141 Ramacciato G, Corigliano N, Mercantini P, Di Benedetto F, Masetti M, Ercolani G, Lauro A, De Ruvo N, Pinna AD. [Prognostic factors after surgical resection for hilar cholangiocarcinoma]. Ann Chir 2006;131:379-85. [PMID: 16806037 DOI: 10.1016/j.anchir.2006.03.006] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
142 Lai EC, Lau WY. Aggressive surgical resection for hilar cholangiocarcinoma. ANZ J Surg. 2005;75:981-985. [PMID: 16336393 DOI: 10.1111/j.1445-2197.2005.03595.x] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 1.6] [Reference Citation Analysis]
143 Lee HY, Kim SH, Lee JM, Kim SW, Jang JY, Han JK, Choi BI. Preoperative assessment of resectability of hepatic hilar cholangiocarcinoma: combined CT and cholangiography with revised criteria. Radiology. 2006;239:113-121. [PMID: 16467211 DOI: 10.1148/radiol.2383050419] [Cited by in Crossref: 139] [Cited by in F6Publishing: 121] [Article Influence: 8.7] [Reference Citation Analysis]
144 Singhal D, van Gulik TM, Gouma DJ. Palliative management of hilar cholangiocarcinoma. Surg Oncol. 2005;14:59-74. [PMID: 16019208 DOI: 10.1016/j.suronc.2005.05.004] [Cited by in Crossref: 50] [Cited by in F6Publishing: 45] [Article Influence: 2.9] [Reference Citation Analysis]
145 Khan SA, Thomas HC, Davidson BR, Taylor-Robinson SD. Cholangiocarcinoma. Lancet. 2005;366:1303-1314. [PMID: 16214602 DOI: 10.1016/s0140-6736(05)67530-7] [Cited by in Crossref: 814] [Cited by in F6Publishing: 852] [Article Influence: 47.9] [Reference Citation Analysis]
146 Jarnagin WR, Bowne W, Klimstra DS, Ben-Porat L, Roggin K, Cymes K, Fong Y, DeMatteo RP, D'Angelica M, Koea J, Blumgart LH. Papillary phenotype confers improved survival after resection of hilar cholangiocarcinoma. Ann Surg 2005;241:703-12; discussion 712-4. [PMID: 15849506 DOI: 10.1097/01.sla.0000160817.94472.fd] [Cited by in Crossref: 141] [Cited by in F6Publishing: 109] [Article Influence: 8.3] [Reference Citation Analysis]
147 Hemming AW, Reed AI, Fujita S, Foley DP, Howard RJ. Surgical management of hilar cholangiocarcinoma. Ann Surg. 2005;241:693-699; discussion 699-702. [PMID: 15849505 DOI: 10.1097/01.sla.0000160701.38945.82] [Cited by in Crossref: 245] [Cited by in F6Publishing: 223] [Article Influence: 14.4] [Reference Citation Analysis]
148 Kitami M, Murakami G, Ko S, Takase K, Tuboi M, Saito H, Nakajima Y, Takahashi S. Spiegel?s Lobe Bile Ducts Often Drain into the Right Hepatic Duct or Its Branches: Study Using Drip-Infusion Cholangiography-Computed Tomography in 179 Consecutive Patients. World J Surg 2004;28:1001-6. [DOI: 10.1007/s00268-004-7483-4] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 0.9] [Reference Citation Analysis]
149 Kondo S, Hirano S, Ambo Y, Tanaka E, Okushiba S, Morikawa T, Katoh H. Forty consecutive resections of hilar cholangiocarcinoma with no postoperative mortality and no positive ductal margins: results of a prospective study. Ann Surg. 2004;240:95-101. [PMID: 15213624 DOI: 10.1097/01.sla.0000129491.43855.6b] [Cited by in Crossref: 219] [Cited by in F6Publishing: 200] [Article Influence: 12.2] [Reference Citation Analysis]
150 Anderson CD, Pinson CW, Berlin J, Chari RS. Diagnosis and treatment of cholangiocarcinoma. Oncologist 2004;9:43-57. [PMID: 14755014 DOI: 10.1634/theoncologist.9-1-43] [Cited by in Crossref: 216] [Cited by in F6Publishing: 219] [Article Influence: 12.0] [Reference Citation Analysis]
151 Soni N, Margarson M. Albumin. Where are we now? Current Anaesthesia & Critical Care 2004;15:61-8. [DOI: 10.1016/j.cacc.2004.01.004] [Cited by in Crossref: 14] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
152 Wang DS, Dou KF, Li KZ, Gao ZQ, Song ZS, Liu ZC. Hepatocellular apoptosis after hepatectomy in obstructive jaundice in rats. World J Gastroenterol 2003; 9(12): 2737-2741 [PMID: 14669324 DOI: 10.3748/wjg.v9.i12.2737] [Cited by in CrossRef: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.5] [Reference Citation Analysis]
153 Kawasaki S, Imamura H, Kobayashi A, Noike T, Miwa S, Miyagawa S. Results of surgical resection for patients with hilar bile duct cancer: application of extended hepatectomy after biliary drainage and hemihepatic portal vein embolization. Ann Surg. 2003;238:84-92. [PMID: 12832969 DOI: 10.1097/01.sla.0000074984.83031.02] [Cited by in Crossref: 143] [Cited by in F6Publishing: 200] [Article Influence: 7.5] [Reference Citation Analysis]
154 Kawasaki S, Imamura H, Kobayashi A, Noike T, Miwa S, Miyagawa S. Results of surgical resection for patients with hilar bile duct cancer: application of extended hepatectomy after biliary drainage and hemihepatic portal vein embolization. Ann Surg. 2003;238:84-92. [PMID: 12832969 DOI: 10.1097/00000658-200307000-00011] [Cited by in Crossref: 17] [Cited by in F6Publishing: 11] [Article Influence: 0.9] [Reference Citation Analysis]
155 Puhalla H, Gruenberger T, Pokorny H, Soliman T, Wrba F, Sponer U, Winkler T, Ploner M, Raderer M, Steininger R. Resection of hilar cholangiocarcinomas: pivotal prognostic factors and impact of tumor sclerosis. World J Surg. 2003;27:680-684. [PMID: 12733000 DOI: 10.1007/s00268-003-6656-x] [Cited by in Crossref: 19] [Cited by in F6Publishing: 14] [Article Influence: 1.0] [Reference Citation Analysis]
156 Strasberg SM. ERCP and surgical intervention in pancreatic and biliary malignancies. Gastrointest Endosc. 2002;56:S213-S217. [PMID: 12447270 DOI: 10.1016/s0016-5107(02)70014-x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
157 Wu C, Yeh D, Lin M, Liu T, P'eng F. Prospective randomized trial of systemic antibiotics in patients undergoing liver resection. British Journal of Surgery 1998;85:489-93. [DOI: 10.1046/j.1365-2168.1998.00606.x] [Cited by in Crossref: 41] [Cited by in F6Publishing: 38] [Article Influence: 2.2] [Reference Citation Analysis]
158 Todoroki T, Kawamoto T, Koike N, Takahashi H, Yoshida S, Kashiwagi H, Takada Y, Otsuka M, Fukao K. Radical resection of hilar bile duct carcinoma and predictors of survival. British Journal of Surgery 2000;87:306-13. [DOI: 10.1046/j.1365-2168.2000.01343.x] [Cited by in Crossref: 92] [Cited by in F6Publishing: 86] [Article Influence: 4.6] [Reference Citation Analysis]
159 Sarmiento JM, Nagorney DM. Hepatic resection in the treatment of perihilar cholangiocarcinoma. Surgical Oncology Clinics of North America 2002;11:893-908. [DOI: 10.1016/s1055-3207(02)00034-0] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 0.8] [Reference Citation Analysis]
160 Wang J, Chi DS, Laffan JJ, Li C, Ferguson DA Jr, Litchfield P, Thomas E. Comparison of cytotoxin genotypes of Helicobacter pylori in stomach and saliva. Dig Dis Sci 2002;47:1850-6. [PMID: 12184541 DOI: 10.1023/a:1016417200611] [Cited by in F6Publishing: 68] [Reference Citation Analysis]
161 Iwahashi N, Nagasaka T, Tezel G, Iwashita T, Asai N, Murakumo Y, Kiuchi K, Sakata K, Nimura Y, Takahashi M. Expression of glial cell line-derived neurotrophic factor correlates with perineural invasion of bile duct carcinoma. Cancer. 2002;94:167-174. [PMID: 11815973 DOI: 10.1002/cncr.10169] [Cited by in Crossref: 26] [Cited by in F6Publishing: 30] [Article Influence: 1.3] [Reference Citation Analysis]
162 Parks R, Garden O. Liver resection for cancer. World J Gastroenterol 2001; 7(6): 766-771 [PMID: 11854897 DOI: 10.3748/wjg.v7.i6.766] [Cited by in CrossRef: 19] [Cited by in F6Publishing: 20] [Article Influence: 0.9] [Reference Citation Analysis]
163 Jarnagin WR, Fong Y, DeMatteo RP, Gonen M, Burke EC, Bodniewicz BS J, Youssef BA M, Klimstra D, Blumgart LH. Staging, resectability, and outcome in 225 patients with hilar cholangiocarcinoma. Ann Surg 2001;234:507-17; discussion 517-9. [PMID: 11573044 DOI: 10.1097/00000658-200110000-00010] [Cited by in Crossref: 887] [Cited by in F6Publishing: 870] [Article Influence: 42.2] [Reference Citation Analysis]
164 Johnson SR, Kelly BS, Pennington LJ, Hanto DW. A single center experience with extrahepatic cholangiocarcinomas. Surgery 2001;130:584-90; discussion 590-2. [PMID: 11602888 DOI: 10.1067/msy.2001.117104] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 0.8] [Reference Citation Analysis]
165 Ijichi M, Makuuchi M, Imamura H, Takayama T. Portal embolization relieves persistent jaundice after complete biliary drainage. Surgery 2001;130:116-8. [DOI: 10.1067/msy.2001.115358] [Cited by in Crossref: 35] [Cited by in F6Publishing: 30] [Article Influence: 1.7] [Reference Citation Analysis]
166 Kitagawa Y, Nagino M, Kamiya J, Uesaka K, Sano T, Yamamoto H, Hayakawa N, Nimura Y. Lymph node metastasis from hilar cholangiocarcinoma: audit of 110 patients who underwent regional and paraaortic node dissection. Ann Surg. 2001;233:385-392. [PMID: 11224627 DOI: 10.1097/00000658-200103000-00013] [Cited by in Crossref: 222] [Cited by in F6Publishing: 199] [Article Influence: 10.6] [Reference Citation Analysis]
167 Marianne O. Photodynamic therapy in the biliary tract. Curr Gastroenterol Rep 2001;3:154-9. [DOI: 10.1007/s11894-001-0013-8] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
168 Manzanera Díaz M, Jiménez Romero C, Moreno González E, Moreno Sanz C, Rodríguez Romano D, Rico Selas P. Tratamiento del colangiocarcinoma hiliar. Cirugía Española 2001;69:159-69. [DOI: 10.1016/s0009-739x(01)71714-9] [Cited by in Crossref: 1] [Article Influence: 0.0] [Reference Citation Analysis]
169 Tsao JI, Nimura Y, Kamiya J, Hayakawa N, Kondo S, Nagino M, Miyachi M, Kanai M, Uesaka K, Oda K. Management of hilar cholangiocarcinoma: comparison of an American and a Japanese experience. Ann Surg. 2000;232:166-174. [PMID: 10903592 DOI: 10.1097/00000658-200008000-00003] [Cited by in Crossref: 182] [Cited by in F6Publishing: 163] [Article Influence: 8.3] [Reference Citation Analysis]
170 Gerhards M, Gonzalez Gonzalez D, ten Hoopen-neumann H, van Gulik T, de Wit TT, Gouma D. Prevention of implantation metastases after resection of proximal bile duct tumours with pre-operative low dose radiation therapy. European Journal of Surgical Oncology (EJSO) 2000;26:480-5. [DOI: 10.1053/ejso.1999.0926] [Cited by in Crossref: 28] [Cited by in F6Publishing: 29] [Article Influence: 1.3] [Reference Citation Analysis]
171 Bathe OF, Pacheco JT, Ossi PB, Franceschi D, Sleeman D, Hutson DG, Russell E, Levi JU, Livingstone AS. A subcutaneous or subfascial jejunostomy is beneficial in the surgical management of extrahepatic bile duct cancers. Surgery 2000;127:506-11. [DOI: 10.1067/msy.2000.105863] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
172 Chamberlain RS, Blumgart LH. Hilar cholangio-carcinoma: a review and commentary. Ann Surg Oncol. 2000;7:55-66. [PMID: 10674450 DOI: 10.1007/s10434-000-0055-4] [Cited by in Crossref: 95] [Cited by in F6Publishing: 89] [Article Influence: 4.3] [Reference Citation Analysis]
173 Neuhaus P, Jonas S, Bechstein WO, Lohmann R, Radke C, Kling N, Wex C, Lobeck H, Hintze R. Extended resections for hilar cholangiocarcinoma. Ann Surg. 1999;230:808-18; discussion 819. [PMID: 10615936 DOI: 10.1097/00000658-199912000-00010] [Cited by in Crossref: 490] [Cited by in F6Publishing: 429] [Article Influence: 22.3] [Reference Citation Analysis]
174 Bismuth H, Majno PE. Hepatobiliary surgery. Journal of Hepatology 2000;32:208-24. [DOI: 10.1016/s0168-8278(00)80427-4] [Cited by in Crossref: 69] [Cited by in F6Publishing: 58] [Article Influence: 3.1] [Reference Citation Analysis]
175 Parks R, Currie E, Madhavan K, Garden O. Increased bacterobilia associated with preoperative biliary drainage in patients with hilar cholangiocarcinoma. HPB 2000;2:375-81. [DOI: 10.1016/s1365-182x(17)30774-8] [Cited by in Crossref: 3] [Article Influence: 0.1] [Reference Citation Analysis]
176 Kosuge T, Yamamoto J, Shimada K, Yamasaki S, Makuuchi M. Improved surgical results for hilar cholangiocarcinoma with procedures including major hepatic resection. Ann Surg. 1999;230:663-671. [PMID: 10561090 DOI: 10.1097/00000658-199911000-00008] [Cited by in Crossref: 254] [Cited by in F6Publishing: 231] [Article Influence: 11.0] [Reference Citation Analysis]
177 Nomura T, Shirai Y, Hatakeyama K. Bacteribilia and cholangitis after percutaneous transhepatic biliary drainage for malignant biliary obstruction. Dig Dis Sci 1999;44:542-6. [PMID: 10080147 DOI: 10.1023/a:1026653306735] [Cited by in Crossref: 43] [Cited by in F6Publishing: 36] [Article Influence: 1.9] [Reference Citation Analysis]
178 van Gulik T, Gerhards M, de Vries J, van Geenen R, de Wit L, Obertop H, Gouma D. Local resection of biliopancreatic cancer. Annals of Oncology 1999;10:S243-6. [DOI: 10.1093/annonc/10.suppl_4.s243] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
179 Povoski SP, Downey RJ, Dudrick PS, Fong Y, Jarnigan WR, Groeger JS, Blumgart LH. The critically ill patient after hepatobiliary surgery. Crit Care 1999;3:139-44. [PMID: 11056738 DOI: 10.1186/cc367] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.2] [Reference Citation Analysis]
180 Margarson MP, Soni N. Serum albumin: touchstone or totem? Anaesthesia. 1998;53: 789-803. [PMID: 9797524 DOI: 10.1046/j.1365-2044.1998.00438.x] [Cited by in Crossref: 190] [Cited by in F6Publishing: 180] [Article Influence: 7.9] [Reference Citation Analysis]
181 Iwatsuki S, Todo S, Marsh J, Madariaga JR, Lee RG, Dvorchik I, Fung JJ, Starzl TE. Treatment of hilar cholangiocarcinoma (Klatskin tumors) with hepatic resection or transplantation. Journal of the American College of Surgeons 1998;187:358-64. [DOI: 10.1016/s1072-7515(98)00207-5] [Cited by in Crossref: 176] [Cited by in F6Publishing: 147] [Article Influence: 7.3] [Reference Citation Analysis]
182 Jonas S, Bechstein WO, Keck H, Veltzke W, Hintze R, Vogl T, Neuhaus P. Partial or total resection of the biliary tract — Surgical strategies for hilar cholangiocarcinoma. Acta Chir Austriaca 1998;30:211-4. [DOI: 10.1007/bf02620207] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
183 Finch MD, Crosbie JL, Currie E, Garden OJ. An 8-year experience of hepatic resection: indications and outcome. Br J Surg. 1998;85:315-319. [PMID: 9529482 DOI: 10.1046/j.1365-2168.1998.00585.x] [Cited by in Crossref: 31] [Cited by in F6Publishing: 30] [Article Influence: 1.3] [Reference Citation Analysis]
184 Madariaga JR, Iwatsuki S, Todo S, Lee RG, Irish W, Starzl TE. Liver resection for hilar and peripheral cholangiocarcinomas: a study of 62 cases. Ann Surg. 1998;227:70-79. [PMID: 9445113 DOI: 10.1097/00000658-199801000-00011] [Cited by in Crossref: 179] [Cited by in F6Publishing: 163] [Article Influence: 7.5] [Reference Citation Analysis]